Showing 1341-1350 of 1496 results for "".
- Christie Brinkley Partners with Merz to Launch New “Milestones of Me” Campaignhttps://modernaesthetics.com/news/christie-brinkley-partners-with-merz-to-launch-new-milestones-of-me-campaign/2471958/Merz Americas is partnering with supermodel, actress, and entrepreneur, Christie Brinkley, to launch a new campaign, “Milestones of Me,” which encourages women to celebrate the moments, big or small, that have made them who they are today. The campaign kicks off in honor of Christie&r
- Leadership Change at Cutera; Preliminary Financial Results for 2018https://modernaesthetics.com/news/leadership-change-at-cutera-preliminary-financial-results-for-2018/2471966/Cutera has announced the resignation of James Reinstein as President, Chief Executive Officer and member of its Board of Directors, effective immediately. The Board has appointed Cutera’s Chief Operating Officer, Jason Richey, as Interim CEO. J. Daniel Plants, Chairman of Cutera, sa
- ASAPS Releases 2019 Plastic Surgery Predictionshttps://modernaesthetics.com/news/asaps-releases-2019-plastic-surgery-predictions/2471968/The coming year will herald less emphasis on celebrity emulation and more emphasis on a tailored, individual look, according to 2019 predictions from
- SENTE Launches Collaborations with Galderma, The HydraFacial Companyhttps://modernaesthetics.com/news/sente-launches-collaborations-with-galderma-the-hydrafacial-company/2471981/New strategic collaborations are intended to broaden the reach of SENTÉ and further expand their disruptive professional grade skin care product portfolio, the company says. Both collaborations will offer consumers the opportunity
- Merz Americas Rolls Out New Xeomin ‘Later Haters' Campaignhttps://modernaesthetics.com/news/merz-americas-rolls-out-new-xeomin-later-haters-campaign/2471983/Merz Americas is launching a new advertising campaign for Xeomin (incobotulinumtoxinA) called “Later Haters,” which urges women to “X out” judgment, stop apologizing for caring about how they look and put an end to feeling
- Sinclair Pharma: Acquisition by Huadong Medicine Company Limited Now Completehttps://modernaesthetics.com/news/sinclair-pharma-acquisition-by-huadong-medicine-company-limited-now-complete/2471988/Huadong Medicine Company Limited (HMC) has acquired Sinclair Pharma Limited, a global aesthetics company headquartered in London, UK, in a deal worth approximately $222 million. HMC is a well-known Chinese pharmaceutical listed company that has established a leading aesthetics business in China a
- Sex and the City's Kristin Davis Partners with Coolsculpting for Denim Denial Programhttps://modernaesthetics.com/news/sex-and-the-citys-kirstin-davis-partners-with-coolsculpting-for-denim-denial-program/2472005/"Sex and the City” star Kristin Davis, is partnering with CoolSculpting for the new "Denim Denial" consumer program.Denim Denial recognizes that every woman has a pair of jeans on the top shelf of her closet or tucked away in a bottom drawer but is holding on to them with the
- Bellus Recognized with Multiple Aesthetic Awardshttps://modernaesthetics.com/news/bellus-recognized-with-multiple-aesthetic-awards/2472006/Bellus Medical topped the charts in eight categories presented by the 2018 Aesthetic Everything® Awards: · Top Aesthetic Companies · Top Skin Care Devices (SkinPen&r
- New from Lumenis: SPLENDOR X Laser Hair Removal Solutionhttps://modernaesthetics.com/news/new-from-lumenis-splendor-x-laser-hair-removal-solution/2472011/Lumenis Ltd. has launched SPLENDOR X, the first solid state laser system equipped with the unique BLEND X technology for fast and effective hair removal and skin solutions. The technology was showcased for the first time at the 2018 American Society of Dermatological Surgery (ASDS) in Phoenix thi
- Galderma Announces the Start of Six New Aesthetic Studieshttps://modernaesthetics.com/news/galderma-announces-the-start-of-six-new-aesthetic-studies/2472014/Galderma Laboratories, L.P. is initiating six new Phase III and IV U.S. aesthetic clinical trials. The six newly initiated studies include three pivotal trials evaluating XpresHAn Technology products; two studies for Dysport evaluating patient satisfaction and